Explore
Systemic Autoinflammatory Diseases—Clinical Rheumatic Challenges Series 2
Eugen Feist (editor)
2024
0 Ungluers have
Faved this Work
Login to Fave
Autoinflammation, as a relatively new field in clinical rheumatology, has gained increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows for a deeper understanding of the closely linked diseases, such as inflammasomopathies, interferonopathies, relopathies, and proteasome-associated syndromes. These insights have not only improved their classification, but have also helped us to identify new treatment targets of pro-inflammatory cytokines, including IL-1ß, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still an urgent medical need, especially in the recognition of syndromes of undifferentiated recurrent fever and reliable outcome measures, for the confirmation of data from controlled clinical trials, in addition to data from registers regarding patients’ long-term experiences. This Special Issue welcomed all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasing linked to immunology.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 3 times via unglue.it ebook links.
- 3 - pdf (CC BY-NC-ND) at Unglue.it.
Keywords
- adult-onset Still’s disease
- anakinra
- ankylosing spondylitis
- anti-IL-1 drugs
- antibody response
- autoimmune
- Autoimmunity
- Autoinflammation
- autoinflammatory disease
- autoinflammatory diseases
- behçet’s disease
- biological drugs
- C-reactive protein (CRP)
- canakinumab
- CAPS
- COVID-19
- cryopyrin-associated periodic syndrome
- Diagnosis
- effectiveness
- epigenetics
- exposure–response
- familial Mediterranean fever
- familial Mediterranean fever (FMF)
- Fatigue
- fever of unknown origin (FUO)
- Fibrosis
- FMF
- functional hyperthermia (FH)
- IL-17
- IL-23
- imaging
- Inflammation
- intracardiac thrombus
- misdiagnoses
- Monitoring
- Morbus Adamantiades–Behçet
- myelodysplastic syndrome
- outcome
- Pain
- Patient survey
- personalized medicine
- psoriatic arthritis
- psychiatric disorder
- psychogenic fever
- remission
- Rheumatoid arthritis
- Rheumatology
- SARS-CoV-2
- SARS-CoV-2 vaccination
- sclerostin
- systemic autoinflammatory diseases
- systemic lupus erythematosus
- thema EDItEUR::M Medicine and Nursing
- thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders
- thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunology
- traps
- vaccination
- VEXAS syndrome
- Wnt/?-catenin pathway
Links
DOI: 10.3390/books978-3-7258-1050-5Editions